Cascadian Therapeutics, Inc. Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2017 12 months to Dec 31, 2017	FY2016 12 months to Dec 31, 2016	FY2015 12 months to Dec 31, 2015	FY2014 12 months to Dec 31, 2014	FY2013 12 months to Dec 31, 2013
Operating expenses
Research and development
General and administrative
Intangible asset impairment
Total operating expenses
Loss from operations
Other income
Investment and other income, net
Interest expense
Change in fair value of warrant liability
Total other income, net
Loss before income taxes
Income tax benefit
Net loss
Loss per share — basic (in Dollars per share)
Shares used to compute diluted loss per share (in Shares)
Net loss attributable to common stockholders
Net loss per share basic and diluted (in dollars per share)
Shares used to compute basic and diluted net loss per share (1) (in shares)

Comments